17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators

Details for Australian Patent Application No. 2003219656 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/348,808 15.01.02 US

4 September 2003 Application Open to Public Inspection

Published as AU-B-2003219656

17 May 2007 Application Accepted

Published as AU-B-2003219656

13 September 2007 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.